Prerecorded Webinar: From Onset to Outcome: Acute Kidney Injury Insights for Healthcare Professionals
Are you a Pharmacy Tech? Check out the Pharmacy Tech version of this course.
Want another way to take this test? Check out the written version of this course.
Acute Kidney Injury (AKI) represents a complex clinical challenge, often demanding swift diagnosis, interdisciplinary collaboration, and judicious therapeutic intervention. The implications of AKI range from transient renal dysfunction to severe complications. The landscape of AKI management continues to evolve, and this continuing education program aims to provide healthcare providers with a holistic perspective on the latest developments in AKI. This monograph will discuss the pathophysiology of AKI, methods by which to detect and risk stratify AKI, and modalities for prevention and treatment.
Recall the pathophysiological mechanisms, causes, and diagnostic biomarkers of acute kidney injury (AKI)
Recall evidence-based therapeutic interventions for AKI
Describe the role of interdisciplinary collaboration in AKI management
Describe tools and techniques to effectively educate and guide patients regarding AKI
II. Diagnostic and Staging Criteria
IV. Etiology and Risk Factors
1. Prerenal AKI
2. Intrarenal AKI
3. Postrenal AKI
V. Clinical Presentation and Diagnosis
1. Patient History
2. Physical Examination
VI. Preventing AKI
VII. Managing AKI
1. Assessing Volume Status and Hemodynamic Stability
2. Scrutinizing Medications
3. Renal Replacement Therapy
VIII. Interdisciplinary Collaboration
IX. Patient Education
X. The Role of the Pharmacists and Staff
XI. Key Takeaways
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in the development of this activity: Liz Fredrickson, PharmD, BCPS, and Pamela Sardo, PharmD, BS. Pamela Sardo was an employee of Rhythm Pharmaceuticals until March 2022 and has no conflicts of interest or relationships regarding the subject matter discussed. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
- Target Audience: Pharmacist
- Contact Hours: 1.0 (0.1 CEUs)
- Activity Release Date: 12/20/2023
- Activity Expiration Date: 12/20/2026
- Activity Type: Knowledge
- UAN: 0669-0000-23-199-H01-P
- Topic: Disease State Management/Drug Therapy
- CeBroker Number: 20-1134188
Preview the Materials:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.